<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01094743</url>
  </required_header>
  <id_info>
    <org_study_id>CR-1636AZ</org_study_id>
    <nct_id>NCT01094743</nct_id>
  </id_info>
  <brief_title>Dispensing Evaluation of a Prototype Contact Lens and a Marketed Contact Lens</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Johnson &amp; Johnson Vision Care, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Johnson &amp; Johnson Vision Care, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>No</is_unapproved_device>
    <is_ppsd>No</is_ppsd>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare visual acuity and redness of eyes between a prototype
      contact lens and an already marketed contact lens.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 1, 2010</start_date>
  <completion_date type="Actual">March 1, 2010</completion_date>
  <primary_completion_date type="Actual">March 1, 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Visual Acuity Monocular</measure>
    <time_frame>after 1 week of lens wear</time_frame>
    <description>Snellen monocular visual acuity measurement</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Visual Acuity Binocular</measure>
    <time_frame>after 1 week of lens wear</time_frame>
    <description>Snellen binocular visual acuity measurement</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Subjective Assessment of Lens Comfort</measure>
    <time_frame>after 1 week of lens wear</time_frame>
    <description>Contact Lens User Experience (CLUE)TM questionnaire: A validated patient-reported outcomes questionnaire to assess patient-experience attributes of soft, disposable contact lenses (comfort, vision, handling, and packaging) in a contact-lens wearing population in the US, ages 18-65. Scores follow a normal distribution with a population average score of 60 (SD 20), where higher scores indicate a more favorable/positive response.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Subjective Assessment of Quality of Vision</measure>
    <time_frame>after 1 week of lens wear</time_frame>
    <description>Contact Lens User Experience (CLUE)TM questionnaire: A validated patient-reported outcomes questionnaire to assess patient-experience attributes of soft, disposable contact lenses (comfort, vision, handling, and packaging) in a contact-lens wearing population in the US, ages 18-65. Scores follow a normal distribution with a population average score of 60 (SD 20), where higher scores indicate a more favorable/positive response.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Limbal Redness</measure>
    <time_frame>after 1 week of lens wear</time_frame>
    <description>Scale of 0 to 4, where 0=None, 2=Trace, 3=Mild, 4=Moderate, 5=Severe.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bulbar Redness</measure>
    <time_frame>after 1 week of lens wear</time_frame>
    <description>Scale of 0 to 4, where 0=None, 2=Trace, 3=Mild, 4=Moderate, 5=Severe.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subjective Assessment of Lens Comfort</measure>
    <time_frame>10 minutes after lens insertion at time of initial lens fitting</time_frame>
    <description>Contact Lens User Experience (CLUE)TM questionnaire: A validated patient-reported outcomes questionnaire to assess patient-experience attributes of soft, disposable contact lenses (comfort, vision, handling, and packaging) in a contact-lens wearing population in the US, ages 18-65. Scores follow a normal distribution with a population average score of 60 (SD 20), where higher scores indicate a more favorable/positive response.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">52</enrollment>
  <condition>Myopia</condition>
  <arm_group>
    <arm_group_label>galyfilcon A prototype lens / lotrafilcon B lens</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>The galyfilcon A prototype lenses will be worn during the first period and lotrafilcon B lenses will be worn during the second period. Each period consists of daily lens wear for one week.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>lotrafilcon B lens / galyfilcon A prototype lens</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>The lotrafilcon B lenses will be worn during the first period and galyfilcon A prototype lenses will be worn during the second period. Each period consists of daily lens wear for one week.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>galyfilcon A prototype lens</intervention_name>
    <description>Silicone hydrogel contact lens</description>
    <arm_group_label>galyfilcon A prototype lens / lotrafilcon B lens</arm_group_label>
    <arm_group_label>lotrafilcon B lens / galyfilcon A prototype lens</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>lotrafilcon B lens</intervention_name>
    <description>Silicon Hydrogel contact lens</description>
    <arm_group_label>galyfilcon A prototype lens / lotrafilcon B lens</arm_group_label>
    <arm_group_label>lotrafilcon B lens / galyfilcon A prototype lens</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. The subject must be at least 18 years of age and no more than 39 years of age.

          2. The subject is a current spherical soft contact lens wearer (defined as a minimum of 6
             hours of DW for a minimum of 1 month prior to the study) and willing to wear the study
             lenses on a daily wear basis (defined as a minimum of 6 hours of wear per day at least
             five days of the week) for the duration of the study.

          3. The subject's optimal vertexed spherical equivalent distance correction must be
             between -1.00 and - 9.00D.

          4. Any cylinder power must be â‰¤ -0.75D.

          5. The subject must have visual acuity best correctable to 20/25+3 or better for each
             eye.

          6. The subject must read and sign the Statement of Informed Consent.

          7. The subject must appear able and willing to adhere to the instructions set forth in
             this clinical protocol.

        Exclusion Criteria:

          1. Ocular or systemic allergies or disease which might interfere with contact lens wear.

          2. Systemic disease or use of medication which might interfere with contact lens wear.

          3. Clinically significant (grade 3 or 4) corneal edema, corneal vascularization, corneal
             staining, or any other abnormalities of the cornea which would contraindicate contact
             lens wear.

          4. Clinically significant (grade 3 or 4) tarsal abnormalities or bulbar injection which
             might interfere with contact lens wear.

          5. Any ocular infection.

          6. Any corneal distortion resulting from previous hard or rigid gas permeable contact
             lens wear.

          7. Pregnancy or lactation.

          8. Diabetes.

          9. Infectious diseases (e.g. hepatitis, tuberculosis) or an immuno-suppressive disease
             (e.g. HIV).

         10. Habitual contact lens type is toric, multifocal, or is worn as extended wear.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>39 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Salem</city>
        <state>Virginia</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 24, 2010</study_first_submitted>
  <study_first_submitted_qc>March 25, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 29, 2010</study_first_posted>
  <results_first_submitted>November 7, 2011</results_first_submitted>
  <results_first_submitted_qc>December 19, 2011</results_first_submitted_qc>
  <results_first_posted type="Estimate">January 25, 2012</results_first_posted>
  <last_update_submitted>September 20, 2017</last_update_submitted>
  <last_update_submitted_qc>September 20, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 20, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Galyfilcon A Prototype Lens / Lotrafilcon B Lens</title>
          <description>All enrolled subjects were to wear both lenses through the course of the study.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Period 1</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="52"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="50"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Unsatisfactory comfort at lens fitting</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
        <period>
          <title>Period 2</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="50"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="50"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Galyfilcon A Prototype Lens / Lotrafilcon B Lens</title>
          <description>All enrolled subjects were to wear both lenses through the course of the study.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="52"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="28" spread="5.76"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="17"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="52"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Visual Acuity Monocular</title>
        <description>Snellen monocular visual acuity measurement</description>
        <time_frame>after 1 week of lens wear</time_frame>
        <population>All completed subjects</population>
        <group_list>
          <group group_id="O1">
            <title>Galyfilcon A Prototype</title>
            <description>All subjects who wore the galyfilcon A prototype lens; VA measured after one week of daily contact lens wear.</description>
          </group>
          <group group_id="O2">
            <title>Lotrafilcon B</title>
            <description>All subjects who wore the lotrafilcon B lens; VA measured after one week of daily contact lens wear.</description>
          </group>
        </group_list>
        <measure>
          <title>Visual Acuity Monocular</title>
          <description>Snellen monocular visual acuity measurement</description>
          <population>All completed subjects</population>
          <units>eyes</units>
          <param>Number</param>
          <units_analyzed>eyes</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="50"/>
                <count group_id="O2" value="50"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>eyes</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="100"/>
                <count group_id="O2" value="100"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>20/15 monocular</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="59"/>
                    <measurement group_id="O2" value="64"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>20/20 monocular</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="40"/>
                    <measurement group_id="O2" value="30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>20/25 monocular</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>20/30 monocular</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Visual Acuity Binocular</title>
        <description>Snellen binocular visual acuity measurement</description>
        <time_frame>after 1 week of lens wear</time_frame>
        <population>All completed subjects</population>
        <group_list>
          <group group_id="O1">
            <title>Galyfilcon A Prototype</title>
            <description>All subjects who wore the galyfilcon A prototype lens; VA measured after one week of daily contact lens wear.</description>
          </group>
          <group group_id="O2">
            <title>Lotrafilcon B</title>
            <description>All subjects who wore the lotrafilcon B lens; VA measured after one week of daily contact lens wear.</description>
          </group>
        </group_list>
        <measure>
          <title>Visual Acuity Binocular</title>
          <description>Snellen binocular visual acuity measurement</description>
          <population>All completed subjects</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="50"/>
                <count group_id="O2" value="50"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>20/15 binocular</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="40"/>
                    <measurement group_id="O2" value="42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>20/20 binocular</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10"/>
                    <measurement group_id="O2" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Subjective Assessment of Lens Comfort</title>
        <description>Contact Lens User Experience (CLUE)TM questionnaire: A validated patient-reported outcomes questionnaire to assess patient-experience attributes of soft, disposable contact lenses (comfort, vision, handling, and packaging) in a contact-lens wearing population in the US, ages 18-65. Scores follow a normal distribution with a population average score of 60 (SD 20), where higher scores indicate a more favorable/positive response.</description>
        <time_frame>after 1 week of lens wear</time_frame>
        <population>Completed subjects</population>
        <group_list>
          <group group_id="O1">
            <title>Galyfilcon A Prototype</title>
            <description>All subjects who wore the galyfilcon A prototype lens; VA measured after one week of daily contact lens wear.</description>
          </group>
          <group group_id="O2">
            <title>Lotrafilcon B</title>
            <description>All subjects who wore the lotrafilcon B lens; VA measured after one week of daily contact lens wear.</description>
          </group>
        </group_list>
        <measure>
          <title>Subjective Assessment of Lens Comfort</title>
          <description>Contact Lens User Experience (CLUE)TM questionnaire: A validated patient-reported outcomes questionnaire to assess patient-experience attributes of soft, disposable contact lenses (comfort, vision, handling, and packaging) in a contact-lens wearing population in the US, ages 18-65. Scores follow a normal distribution with a population average score of 60 (SD 20), where higher scores indicate a more favorable/positive response.</description>
          <population>Completed subjects</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="50"/>
                <count group_id="O2" value="50"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="66.23" spread="24.112"/>
                    <measurement group_id="O2" value="55" spread="21.844"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Limbal Redness</title>
        <description>Scale of 0 to 4, where 0=None, 2=Trace, 3=Mild, 4=Moderate, 5=Severe.</description>
        <time_frame>after 1 week of lens wear</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Galyfilcon A Prototype</title>
            <description>All subjects who wore the galyfilcon A prototype lens; VA measured after one week of daily contact lens wear.</description>
          </group>
          <group group_id="O2">
            <title>Lotrafilcon B</title>
            <description>All subjects who wore the lotrafilcon B lens; VA measured after one week of daily contact lens wear.</description>
          </group>
        </group_list>
        <measure>
          <title>Limbal Redness</title>
          <description>Scale of 0 to 4, where 0=None, 2=Trace, 3=Mild, 4=Moderate, 5=Severe.</description>
          <units>eyes</units>
          <param>Number</param>
          <units_analyzed>eyes</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="50"/>
                <count group_id="O2" value="50"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>eyes</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="100"/>
                <count group_id="O2" value="100"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Grade 0 None</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="37"/>
                    <measurement group_id="O2" value="35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Grade 1 Trace</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="61"/>
                    <measurement group_id="O2" value="61"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Grade 2 Mild</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Bulbar Redness</title>
        <description>Scale of 0 to 4, where 0=None, 2=Trace, 3=Mild, 4=Moderate, 5=Severe.</description>
        <time_frame>after 1 week of lens wear</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Galyfilcon A Prototype</title>
            <description>All subjects who wore the galyfilcon A prototype lens; VA measured after one week of daily contact lens wear.</description>
          </group>
          <group group_id="O2">
            <title>Lotrafilcon B</title>
            <description>All subjects who wore the lotrafilcon B lens; VA measured after one week of daily contact lens wear.</description>
          </group>
        </group_list>
        <measure>
          <title>Bulbar Redness</title>
          <description>Scale of 0 to 4, where 0=None, 2=Trace, 3=Mild, 4=Moderate, 5=Severe.</description>
          <units>eyes</units>
          <param>Number</param>
          <units_analyzed>eyes</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="50"/>
                <count group_id="O2" value="50"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>eyes</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="100"/>
                <count group_id="O2" value="100"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Grade 0 None</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="44"/>
                    <measurement group_id="O2" value="34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Grade 1 Trace</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="50"/>
                    <measurement group_id="O2" value="64"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Grade 2 Mild</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                    <measurement group_id="O2" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Subjective Assessment of Quality of Vision</title>
        <description>Contact Lens User Experience (CLUE)TM questionnaire: A validated patient-reported outcomes questionnaire to assess patient-experience attributes of soft, disposable contact lenses (comfort, vision, handling, and packaging) in a contact-lens wearing population in the US, ages 18-65. Scores follow a normal distribution with a population average score of 60 (SD 20), where higher scores indicate a more favorable/positive response.</description>
        <time_frame>after 1 week of lens wear</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Galyfilcon A Prototype</title>
            <description>All subjects who wore the galyfilcon A prototype lens; VA measured after one week of daily contact lens wear.</description>
          </group>
          <group group_id="O2">
            <title>Lotrafilcon B</title>
            <description>All subjects who wore the lotrafilcon B lens; VA measured after one week of daily contact lens wear.</description>
          </group>
        </group_list>
        <measure>
          <title>Subjective Assessment of Quality of Vision</title>
          <description>Contact Lens User Experience (CLUE)TM questionnaire: A validated patient-reported outcomes questionnaire to assess patient-experience attributes of soft, disposable contact lenses (comfort, vision, handling, and packaging) in a contact-lens wearing population in the US, ages 18-65. Scores follow a normal distribution with a population average score of 60 (SD 20), where higher scores indicate a more favorable/positive response.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="50"/>
                <count group_id="O2" value="50"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="63.22" spread="25.345"/>
                    <measurement group_id="O2" value="59.83" spread="20.036"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Subjective Assessment of Lens Comfort</title>
        <description>Contact Lens User Experience (CLUE)TM questionnaire: A validated patient-reported outcomes questionnaire to assess patient-experience attributes of soft, disposable contact lenses (comfort, vision, handling, and packaging) in a contact-lens wearing population in the US, ages 18-65. Scores follow a normal distribution with a population average score of 60 (SD 20), where higher scores indicate a more favorable/positive response.</description>
        <time_frame>10 minutes after lens insertion at time of initial lens fitting</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Galyfilcon A Prototype</title>
            <description>All subjects who wore the galyfilcon A prototype lens; VA measured after one week of daily contact lens wear.</description>
          </group>
          <group group_id="O2">
            <title>Lotrafilcon B</title>
            <description>All subjects who wore the lotrafilcon B lens; VA measured after one week of daily contact lens wear.</description>
          </group>
        </group_list>
        <measure>
          <title>Subjective Assessment of Lens Comfort</title>
          <description>Contact Lens User Experience (CLUE)TM questionnaire: A validated patient-reported outcomes questionnaire to assess patient-experience attributes of soft, disposable contact lenses (comfort, vision, handling, and packaging) in a contact-lens wearing population in the US, ages 18-65. Scores follow a normal distribution with a population average score of 60 (SD 20), where higher scores indicate a more favorable/positive response.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="50"/>
                <count group_id="O2" value="50"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="76.67" spread="18.487"/>
                    <measurement group_id="O2" value="65" spread="19.842"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Galyfilcon A Prototype Lens / Lotrafilcon B Lens</title>
          <description>All enrolled subjects were to wear both lenses through the course of the study.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="52"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="52"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>Publication requires agreement and written consent from the Sponsor.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Huan Sheng, MD, PhD</name_or_title>
      <organization>Johnson &amp; Johnson Vision Care</organization>
      <phone>1-904-443-3440</phone>
      <email>HSheng2@its.jnj.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

